Pacira Biosciences, Inc. (PCRX)
Pacira Biosciences Market Cap : 1.455B for Nov. 16, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 16, 2026 | 1.455B |
| November 13, 2026 | 1.455B |
| November 12, 2026 | 1.455B |
| November 11, 2026 | 1.455B |
| November 10, 2026 | 1.456B |
| November 09, 2026 | 1.455B |
| November 06, 2026 | 1.453B |
| November 05, 2026 | 1.453B |
| November 04, 2026 | 1.452B |
| November 03, 2026 | 1.452B |
| November 02, 2026 | 1.450B |
| October 30, 2026 | 1.449B |
| October 29, 2026 | 1.449B |
| October 28, 2026 | 1.449B |
| October 27, 2026 | 1.450B |
| October 26, 2026 | 1.449B |
| October 23, 2026 | 1.450B |
| October 22, 2026 | 1.447B |
| October 21, 2026 | 1.447B |
| October 20, 2026 | 1.449B |
| October 19, 2026 | 1.447B |
| October 16, 2026 | 1.447B |
| October 15, 2026 | 1.447B |
| October 14, 2026 | 1.450B |
| October 13, 2026 | 1.446B |
| Date | Value |
|---|---|
| October 12, 2026 | 1.448B |
| October 09, 2026 | 1.446B |
| October 08, 2026 | 1.449B |
| October 07, 2026 | 1.004B |
| October 06, 2026 | 986.00M |
| October 05, 2026 | 997.55M |
| October 02, 2026 | 1.004B |
| October 01, 2026 | 995.96M |
| September 30, 2026 | 997.55M |
| September 29, 2026 | 1.021B |
| September 28, 2026 | 1.011B |
| September 25, 2026 | 1.000B |
| September 24, 2026 | 1.018B |
| September 23, 2026 | 980.82M |
| September 22, 2026 | 983.61M |
| September 21, 2026 | 960.12M |
| September 18, 2026 | 983.21M |
| September 17, 2026 | 974.85M |
| September 16, 2026 | 991.97M |
| September 15, 2026 | 958.92M |
| September 14, 2026 | 982.81M |
| September 11, 2026 | 1.010B |
| September 10, 2026 | 1.002B |
| September 09, 2026 | 1.031B |
| September 08, 2026 | 1.030B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Viatris, Inc. | 23.78B |
| Organon & Co. | 3.650B |
| ANI Pharmaceuticals, Inc. | 1.623B |
| Corcept Therapeutics, Inc. | 7.570B |
| Veru, Inc. | 35.46M |
Market Cap Related Metrics
| PE Ratio | 39.51 |
| PS Ratio | 2.025 |
| PEG Ratio | 0.3692 |
| Price to Book Value | 2.043 |
| Price to Free Cash Flow | 8.906 |
| Price | 36.48 |
| Earnings Yield | 2.53% |
| PEGY Ratio | 0.3692 |
| Operating PE Ratio | 48.52 |
| Normalized PE Ratio | 43.28 |